PSZ

Devices Detecting Influenza A, B, And C Virus Antigens

Product code
PSZ
Device name
Devices Detecting Influenza A, B, And C Virus Antigens
Device class
Class 2
21 CFR
21 CFR 866.3328
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
4
Summaries archived here
4 (direct download)
510(k) clearances (all years, FDA)
72 (all years; only the last 3 years are listed here)

FDA classification definition

An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (4)

Last three years. Most recent: 2026-01-15.

NumberDecision dateApplicantDevice nameSummary
K2522832026-01-15Nano-Ditech CorporationNano-Check Influenza A+B TestPDF
K2503982025-07-03Innovita (Tangshan) Biological Technol…Innovita Flu A/B Antigen Rapid TestPDF
K2411882025-04-18SEKISUI Diagnostics, LLCAcucy® Influenza A&B Test with the Acucy® 2 SystemPDF
K2324342023-12-05BdBD Veritor™ System for Rapid Detection of Flu A+B CL…PDF

4 summaries are archived here for direct download.

Official FDA classification page: PSZ
Classification and pathway per current FDA publications. Data from openFDA (CC0).